Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 08:35 am Sale |
2024-09-30 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 2,709,991 4.000% |
-540,000 (-16.62%) |
Filing History |
| 2024-02-14 4:44 pm Sale |
2023-12-31 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 3,249,991 5.500% |
-360,487 (-9.98%) |
Filing History |
| 2023-02-13 4:49 pm Sale |
2022-12-31 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 3,610,478 7.200% |
-1,445,074 (-28.58%) |
Filing History |
| 2022-02-14 3:18 pm Sale |
2021-12-31 | 13G | Replimune Group, Inc. REPL |
Omega Fund IV L.P. | 5,055,552 10.600% |
-274,231 (-5.15%) |
Filing History |
| 2021-02-12 2:32 pm Sale |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
Omega Fund IV L.P. | 777,996 2.300% |
-1,004,155 (-56.35%) |
Filing History |
| 2020-08-06 4:47 pm Purchase |
2020-07-28 | 13G | Alpine Immune Sciences, Inc. ALPN |
Omega Fund IV L.P. | 1,670,370 6.900% |
1,670,370 (New Position) |
Filing History |